THE IMPACT OF DIRECT-ACTING ANTIVIRAL TREATMENT FOR HCV ON HEPATOCELLULAR CARCINOMA RISK IN A LARGE POPULATION-BASED COHORT STUDY

被引：0
|
作者：
Janjua, Naveed [1 ,2 ,3 ]
Wong, Stanley [1 ]
Garcia, Hector Velasquez [1 ]
Jeong, Dahn [1 ,2 ]
Binka, Mawuena [1 ]
Makuza, Jean Damascene [1 ,2 ]
Bartlett, Sofia [4 ]
Ramji, Alnoor [5 ]
Yu, Amanda [1 ]
Adu, Prince Asumadu [2 ]
Yoshida, Eric M. [2 ]
Darvishian, Maryam [6 ]
Alvarez, Maria [1 ]
Krajden, Mel [1 ]
机构：
[1] British Columbia Ctr Dis Control, Vancouver, BC, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[3] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
[4] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[5] Univ British Columbia, Div Gastroenterol, Dept Med, Vancouver, BC, Canada
[6] British Columbia Canc Res Ctr, Vancouver, BC, Canada
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1280
引用
收藏
页码：S372 / S373
页数：2
相关论文
共 50 条
  • [1] Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study
    Janjua, Naveed Z.
    Wong, Stanley
    Abdia, Younathan
    Jeong, Dahn
    Buller-Taylor, Terri
    Adu, Prince A.
    Samji, Hasina
    Wilton, James
    Pearce, Margo
    Butt, Zahid A.
    Yu, Amanda
    Binka, Mawuena
    Bartlett, Sofia
    Alvarez, Maria
    Krajden, Mel
    JOURNAL OF HEPATOLOGY, 2021, 75 (05) : 1049 - 1057
  • [2] The impact of SVR from direct acting antiviral and interferon-based treatments for HCV on hepatocellular carcinoma risk in a large population based cohort
    Janjua, Naveed
    Wong, Stanley
    Rossi, Carmine
    Darvishian, Maryam
    Yu, Amanda
    Butt, Zahid A.
    Yoshida, Eric
    Ramji, Alnoor
    Feld, Jordan
    Binka, Mawuena
    Bartlett, Sofia
    Pearce, Margo
    Alvarez, Maria
    Samji, Hasina
    Tyndall, Mark
    Krajden, Mel
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E736 - E736
  • [3] Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
    Dash, Srikanta
    Aydin, Yucel
    Widmer, Kyle E.
    Nayak, Leela
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2020, 7 : 45 - 76
  • [4] The impact of SVR from direct-acting antiviral- and interferon-based treatments for HCV on hepatocellular carcinoma risk
    Janjua, Naveed Z.
    Wong, Stanley
    Darvishian, Maryam
    Butt, Zahid A.
    Yu, Amanda
    Binka, Mawuena
    Alvarez, Maria
    Woods, Ryan
    Yoshida, Eric M.
    Ramji, Alnoor
    Feld, Jordan
    Krajden, Mel
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (08) : 781 - 793
  • [5] HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
    Ioannou, George N.
    Green, Pamela K.
    Berry, Kristin
    JOURNAL OF HEPATOLOGY, 2018, 68 (01) : 25 - 32
  • [6] Direct-acting antiviral treatment for patients with hepatocellular carcinoma
    Kushner, Tatyana
    Dieterich, Douglas
    Saberi, Behnam
    CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (03) : 132 - 139
  • [7] Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV
    Jilkova, Zuzana Macek
    Saleem, Komal
    Afzal, Samia
    Decaens, Thomas
    LIVERS, 2021, 1 (04): : 313 - 321
  • [8] Direct-acting antiviral treatment for HCV
    Goutzamanis, Stelliana
    Doyle, Joseph
    Thompson, Alexander
    Hellard, Margaret
    Higgs, Peter
    LANCET INFECTIOUS DISEASES, 2016, 16 (12): : 1325 - 1326
  • [9] Effects of direct-acting antiviral therapy for patients with advanced hepatocellular carcinoma and concomitant hepatitis C-A population-based cohort study
    Tsai, H-Y
    Chang, H-P
    Chen, C-J
    Hsu, W-L
    Huang, L-Y
    Lee, P-C
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (23) : 7543 - 7552
  • [10] The Impact of Direct-acting Antiviral Therapy for Hepatitis C on Hepatocellular Carcinoma Risk
    Feng Su
    George N. Ioannou
    Current Hepatology Reports, 2018, 17 (4) : 377 - 384
12345